By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunovaccine Inc. 

1819 Granville Street
Suite 303
Halifax  Nova Scotia  B3J 3R1  Canada
Phone: 902-492-1819 Fax: 902-492-0888




Company News
Immunovaccine Inc. Reports Positive Results From Two Anthrax Studies 9/9/2013 7:45:45 AM
Immunovaccine Inc. Files for Name and Symbol Change; After Necessary Approvals, Company Will be Called: Tauriga Sciences, Inc. 3/4/2013 9:42:22 AM
Immunovaccine Inc. Investor Presentation Now Available for on-Demand Viewing at 10/8/2012 10:49:44 AM
Immunovaccine Inc. to Webcast, Live, at on October 4th 10/4/2012 12:21:55 PM
Immunovaccine Inc. Announces Appointment of John Trizzino as CEO 9/12/2011 7:09:10 AM
Immunovaccine Inc. Announces Resignation of President and Chief Executive Officer 4/14/2011 11:34:16 AM
Immunovaccine Inc. to Present at Biotech Showcase(TM) 2011 1/5/2011 9:57:18 AM
Immunovaccine Inc. Announces Issuance of Common Shares to a Consultant 1/5/2011 9:14:26 AM
Immunovaccine Inc. Grants Stock Options 12/20/2010 8:48:45 AM
Immunovaccine Inc. Announces Preliminary Safety Results from Phase I Clinical Trial of DPX-0907 Cancer Vaccine 12/15/2010 8:47:51 AM